Tom Kindlon
Senior Member (Voting Rights)
Submissions are now sought for a special journal edition, "ME/CFS - The Severely & Very Severely Affected"
Guest Editors:
Dr. Kenneth Friedman
Laboratory Corporation of America Holdings, Burlington, United States
Dr. Lucinda Bateman
Bateman Horne Center, Salt Lake City, United States
Prof. Kenny Leo De Meirleir
Professor emeritus Physiology, Pathophysiology and Medicine, Vrije Universiteit Brussel
Deadline for manuscript submissions:
31 December 2020
More details including the email addresses for the guest editors are in this file which I have uploaded in 2 places:
<https://www.dropbox.com/s/6lnhn6xo8d8eh2w/me_cfs_issue_Flyer.pdf?dl=0>
<https://www.mediafire.com/file/klrm1p0ilnuubrw/me_cfs_issue_Flyer.pdf/file>
I have also uploaded with this post.
I have posted some details on Twitter and Facebook. Here are links to facilitate sharing:
Guest Editors:
Dr. Kenneth Friedman
Laboratory Corporation of America Holdings, Burlington, United States
Dr. Lucinda Bateman
Bateman Horne Center, Salt Lake City, United States
Prof. Kenny Leo De Meirleir
Professor emeritus Physiology, Pathophysiology and Medicine, Vrije Universiteit Brussel
Deadline for manuscript submissions:
31 December 2020
Message from the Guest Editors
“ME/CFS—The Severely and Very Severely Affected” is a proposed themed Special Issue of Healthcare concerning housebound and bedbound Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) patients. Our intent is to redefine ME/CFS as the serious disease that it is. Up to this point in time, all literature and case definitions of ME/CFS have excluded severely and very severely affected patients, and diagnosis, patient management, and case definitions have been based on the ambulatory ME/CFS patient. Although never formally studied, it is estimated that twenty-five percent of ME/CFS patients are either severely or very severely affected. What other disease’s diagnosis, patient care, and case definition exclude the most severely ill twenty-five percent?
We aim to document, describe, and promulgate what can and should be done for this hidden patient population. By focusing on the severely affected, it is our hope that the pathophysiological nature of the disease will be better accepted and understood, and effective methods of symptom reduction and patient improvement will be placed in the medical literature.
More details including the email addresses for the guest editors are in this file which I have uploaded in 2 places:
<https://www.dropbox.com/s/6lnhn6xo8d8eh2w/me_cfs_issue_Flyer.pdf?dl=0>
<https://www.mediafire.com/file/klrm1p0ilnuubrw/me_cfs_issue_Flyer.pdf/file>
I have also uploaded with this post.
I have posted some details on Twitter and Facebook. Here are links to facilitate sharing:
Attachments
Last edited: